Search results for "patency"

showing 9 items of 49 documents

MR angiography of the pedal arteries with gadobenate dimeglumine, a contrast agent with increased relaxivity, and comparison with selective intraarte…

2007

Purpose To compare gadobenate dimeglumine (Gd-BOPTA)–enhanced MR angiography (i.e., contrast-enhanced MRA [CE-MRA]) of the pedal vasculature with selective digital subtraction angiography (DSA) in patients with peripheral arterial occlusive disease (PAOD). Materials and Methods A total of 22 patients with PAOD were prospectively examined at 1.5T. For contrast enhancement, 0.1 mmol/kg body weight of Gd-BOPTA were applied. MRA consisted of dynamic imaging with acquisition of six consecutive data sets. Acquisition time for each data set was 24 seconds, voxel size was 1.0 × 1.0 × 1.3 mm3. A total of 20 out of 22 patient underwent selective DSA, two patients fine-needle DSA. DSA and MRA were per…

AdultMalemedicine.medical_specialtyImage qualitymedia_common.quotation_subjectDynamic imagingContrast MediaArterial Occlusive DiseasesMegluminemedicineOrganometallic CompoundsContrast (vision)HumansRadiology Nuclear Medicine and imagingIn patientcardiovascular diseasesProspective StudiesGADOBENATE DIMEGLUMINEVascular Patencymedia_commonAgedAged 80 and overPeripheral Vascular Diseasesmedicine.diagnostic_testbusiness.industryFootMr angiographyAngiography Digital SubtractionDigital subtraction angiographyMiddle Agedmedicine.diseasebody regionsStenosiscardiovascular systemFemaleRadiologyNuclear medicinebusinessMagnetic Resonance Angiographycirculatory and respiratory physiologyJournal of magnetic resonance imaging : JMRI
researchProduct

Infrequent early recanalization of greater saphenous vein after endovenous laser treatment

2003

Abstract Objective The frequency of recanalization of the greater saphenous vein (GSV) after endovenous laser treatment (ELT) is unclear. This study was undertaken to establish the incidence of early recanalization after ELT and to study the histopathologic features of reperfused and excised GSV. Methods One hundred nine GSV in 85 consecutive patients with clinical stage C 2-6 E P,S A S,P,D P R disease were treated with ELT. Twelve months of follow-up with duplex scanning at regular intervals was possible in 104 treated veins (95.4%) in 82 patients (96.5%). Recanalized vessels were removed surgically and examined at histopathology. Results ELT-induced occlusion proved permanent at duplex sc…

AdultMaleReoperationmedicine.medical_specialtyHigh ligationAdolescentmedicine.medical_treatmentGreater saphenous veinRisk AssessmentSeverity of Illness IndexCohort StudiesDuplex scanningOcclusionmedicineHumansSaphenous VeinProspective StudiesStage (cooking)Vascular PatencyAgedAged 80 and overUltrasonography Doppler Duplexbusiness.industryBiopsy NeedleEndovenous laser treatmentMiddle AgedImmunohistochemistrySurgeryTreatment OutcomeLower ExtremityVenous InsufficiencyFemaleSurgeryHistopathologyLaser TherapyCardiology and Cardiovascular MedicinebusinessSaphenous veinsFollow-Up StudiesJournal of Vascular Surgery
researchProduct

Contemporary results with the biosynthetic glutaraldehyde denatured ovine collagen graft (Omniflow II) in femoropopliteal position

2020

Abstract Objective The objective of this study was to analyze the outcome of a contemporary series of femoropopliteal bypass operations with the glutaraldehyde denatured polyester mesh-reinforced ovine collagen prosthesis (OCP; Omniflow II [LeMaitre Vascular, Inc, Burlington, Mass]). The experience of two tertiary centers regarding long-term graft function, secondary reinterventions, and biodegeneration of the OCP prosthesis is presented. Methods Between January 2006 and January 2014, a series of 205 consecutive operations with the OCP in the femoropopliteal position (54 above knee and 151 below knee) were performed in 194 patients in 202 limbs for disabling claudication (72), chronic criti…

MaleReoperationmedicine.medical_specialtyPolyestersmedicine.medical_treatmentIschemia030204 cardiovascular system & hematologyProsthesisBlood Vessel Prosthesis Implantation03 medical and health sciencesPostoperative Complications0302 clinical medicineAneurysmBlood vessel prosthesisOcclusionmedicineAnimalsHumansVascular PatencyPopliteal Artery030212 general & internal medicineSheep DomesticVascular PatencyAgedRetrospective StudiesAged 80 and overBioprosthesisPeripheral Vascular Diseasesmedicine.diagnostic_testbusiness.industryAngiographyMiddle AgedSurgical MeshLimb Salvagemedicine.diseaseBlood Vessel ProsthesisSurgeryFemoral ArteryGlutaralAngiographyFemaleSurgeryCollagenmedicine.symptomCardiology and Cardiovascular MedicineClaudicationbusinessJournal of Vascular Surgery
researchProduct

Spontaneous gastroesophageal reflux and airway patency during the night in adult asthmatics

2000

Controversies still exist on the role of nighttime gastroesophageal reflux (GER) in precipitating nocturnal asthma. We tested the relationship between GER and nocturnal bronchoconstriction by continuously and simultaneously monitoring both respiratory resistances and esophageal pH in seven asthmatics with moderate to severe GER disease. Twenty-nine GER episodes were found during the study night lasting more than 5 min (LGER) and 72 not longer than 5 min (SGER). Both long (LGER) and short (SGER) gastroesophageal refluxes were able to maintain significantly higher lower respiratory resistances (RLR) at the resolution of each GER episode (RLR(e)) with respect to baseline values. RLR, expressed…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAirway patencyPrognosiBronchoconstrictionPolysomnographySettore MED/10 - Malattie Dell'Apparato RespiratorioNocturnalEsophaguCritical Care and Intensive Care MedicineSeverity of Illness IndexGastroenterologyEsophagusInternal medicinemedicineHumansRespiratory systemAsthmaEsophageal diseasebusiness.industryAirway ResistancefungiRespiratory diseaseRefluxHydrogen-Ion ConcentrationMiddle AgedPrognosismedicine.diseaseAsthmaCircadian RhythmSurgeryGastroesophageal RefluxFemaleBronchoconstrictionmedicine.symptombusinessHuman
researchProduct

Mid-Term Results of Endovascular Aneurysm Sealing in the Treatment of Abdominal Aortic Aneurysm With Unfavorable Morphology.

2020

Purpose: To report mid-term results of endovascular aneurysm sealing (EVAS) of abdominal aortic aneurysms (AAA) deemed unsuitable for a standard endovascular aneurysm repair (EVAR). Methods: A prospectively maintained database of 42 patients with EVAR-unfavorable anatomy treated by EVAS combined with chimney grafts in case of the proximal AAA neck shorter than 5 mm was analyzed. Early outcomes included final angiographic result, intra- and early post-operative deaths, and complications. Mid-term outcomes included all-cause mortality (ACM), aneurysm-related mortality (ARM), patency of the stents, occurrence of endoleaks, serious complications and graft failures defined as the AAA growth of m…

Malemedicine.medical_specialtyTime FactorsDatabases Factualmedicine.medical_treatmentMid term results030204 cardiovascular system & hematologyEndovascular aneurysm repairRisk AssessmentNellix device03 medical and health sciencesBlood Vessel Prosthesis Implantationabdominal aortic aneurysm0302 clinical medicineAneurysmPostoperative ComplicationsRisk Factorschimney graftsmedicineHumans030212 general & internal medicineVascular PatencyAgedendovascular aneurysm sealingbusiness.industryEndovascular ProceduresGeneral MedicineMiddle Agedmedicine.diseaseAbdominal aortic aneurysmSurgeryBlood Vessel ProsthesisProsthesis FailureTreatment OutcomeSurgeryFemaleStentsCardiology and Cardiovascular Medicinebusinessoutside IFUAortic Aneurysm AbdominalVascular and endovascular surgery
researchProduct

A Multicenter Experience With a New Fenestrated-Branched Device for Endovascular Repair of Thoracoabdominal Aortic Aneurysms.

2018

To investigate the outcomes of patients who were treated for thoracoabdominal aortic aneurysms (TAAAs) using custom-made fenestrated-branched stent-grafts.A consecutive series of 108 patients (mean age 73.5 years; 73 men) with TAAA were treated with E-xtra Design Engineering customized fenestrated-branched stent-grafts between November 2011 and January 2017. Data on baseline characteristics, procedures, and clinical follow-up were collected from 6 regional European surgical centers for retrospective analysis of endoleaks, reinterventions, and target vessel patency. The median aneurysm diameter was 6.75 cm (range 5.5-13). The distribution of the TAAA according to the modified Crawford classi…

Malemedicine.medical_specialtyTime Factors030204 cardiovascular system & hematologyThoracoabdominal Aortic AneurysmsProsthesis Design03 medical and health sciencesBlood Vessel Prosthesis Implantation0302 clinical medicinePostoperative ComplicationsRisk FactorsmedicineHumansRadiology Nuclear Medicine and imagingcardiovascular diseases030212 general & internal medicineVascular PatencyAgedRetrospective StudiesAged 80 and overAortic Aneurysm Thoracicbusiness.industryEndovascular ProceduresSpinal cord ischemiaMiddle AgedSurgeryBlood Vessel ProsthesisEuropesurgical procedures operativeTreatment Outcomecardiovascular systemSurgeryFemaleStentsCardiology and Cardiovascular MedicinebusinessJournal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
researchProduct

The DETOUR procedure: no more need for conventional bypass surgery?

2018

Background Long segment occlusive disease in the superficial femoral artery remains a treatment challenge despite advances in open surgical and endovascular approaches. We report initial clinical results of an entirely new procedure to perform percutaneous femoro-popliteal bypass using the DETOUR System. First-in-human patients were performed in New Zealand from December 2013 to June 2014. After modifications to the technique and devices had significantly refined the procedure, the Detour I Trial commenced. Methods Review of initial results in the first five patients treated at a single site enrolled in IRB-approved, prospective clinical study using the DETOUR System. All patients signed in…

Malemedicine.medical_specialtyTime FactorsPercutaneousComputed Tomography AngiographyDeep veinmedicine.medical_treatmentFemoral veinConstriction PathologicFemoral artery030204 cardiovascular system & hematology030218 nuclear medicine & medical imagingBlood Vessel Prosthesis ImplantationPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineRecurrenceBlood vessel prosthesismedicine.arterymedicineHumansProspective StudiesVascular PatencyAgedAged 80 and overbusiness.industryEndovascular ProceduresStentPhlebographyGeneral MedicineMiddle AgedLatviaPopliteal arteryBlood Vessel ProsthesisSurgeryFemoral ArteryTreatment Outcomemedicine.anatomical_structureBypass surgeryFemaleStentsSurgeryCardiology and Cardiovascular MedicinebusinessThe Journal of Cardiovascular Surgery
researchProduct

Use of covered chimney stents for pararenal aortic pathologies is safe and feasible with excellent patency and low incidence of endoleaks.

2012

Background To present the clinical experience of consecutive series with use of balloon-expandable and self-expanding chimney endografts (balloon-expandable covered stent group [BECS] vs self-expanding covered stent group [SECS]) in the endovascular treatment of challenging aortic pathologies requiring renal and/or visceral revascularization. Methods Between January 2009 and May 2011, data for 37 high-risk patients from one center and 35 patients from another institution, with pararenal aortic pathologies treated by the chimney endovascular technique, were prospectively collected. The chimney-graft technique is based on the deployment of a covered or bare-metal stent parallel to the aortic …

Malemedicine.medical_specialtyTime FactorsEndoleakmedicine.medical_treatmentEVAR aneurysm chimney periscopesAortic Diseases610 Medicine & healthKaplan-Meier EstimateRevascularizationBalloonProsthesis DesignSettore MED/22 - Chirurgia VascolareAortographyRisk Assessment2705 Cardiology and Cardiovascular MedicineBlood Vessel Prosthesis ImplantationPredictive Value of TestsRisk FactorsAngioplastyGermanymedicineHumansVascular PatencyComputed tomography angiographyAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbusiness.industryStentPerioperativemedicine.disease10020 Clinic for Cardiac Surgery2746 SurgerySurgeryBlood Vessel ProsthesisStenosisTreatment OutcomeCuffSurgeryFemaleStentsRadiologyCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedAngioplasty BalloonSwitzerlandJournal of vascular surgery
researchProduct

Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry.

2020

OBJECTIVE To investigate the outcomes after bioresorbable scaffold (BRS) implantation in calcified coronary lesions. In calcified coronary lesions, durable metallic drug-eluting stent (DES) implantation is associated with worse clinical outcomes compared to noncalcified lesions. Although not recommended, BRSs were frequently implanted in calcified lesions in clinical practice. Their outcome is not well investigated. METHODS Between November 2013 and January 2016, 3326 patients were enrolled in the German-Austrian ABSORB ReglstRy (GABI-R). Lesion calcification severity was classified into no (n = 1144), mild (n = 1306), and moderate-to-severe (n = 690) calcification. RESULTS Patients with ca…

Target lesionMalemedicine.medical_specialtymedicine.medical_treatmentMyocardial InfarctionLong Term Adverse EffectsCoronary Artery Disease030204 cardiovascular system & hematologySeverity of Illness IndexLesion03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionPostoperative ComplicationsInternal medicineDiabetes mellitusAbsorbable ImplantsmedicineHumans030212 general & internal medicineMyocardial infarctionRegistriesVascular CalcificationVascular PatencyTissue Scaffoldsbusiness.industryIncidence (epidemiology)StentDrug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseThrombosisCoronary VesselsCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessCalcificationCoronary artery disease
researchProduct